Paushak Ltd
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
- Market Cap ₹ 1,614 Cr.
- Current Price ₹ 5,236
- High / Low ₹ 6,399 / 4,464
- Stock P/E 28.6
- Book Value ₹ 1,417
- Dividend Yield 0.38 %
- ROCE 16.5 %
- ROE 12.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 8.13% over past five years.
- Company has a low return on equity of 13.5% over last 3 years.
- Dividend payout has been low at 10.4% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Commodities BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | 54 | 69 | 78 | 72 | 105 | 140 | 138 | 141 | 150 | 212 | 206 | 215 | |
39 | 43 | 52 | 61 | 60 | 75 | 99 | 95 | 91 | 96 | 137 | 142 | 148 | |
Operating Profit | 12 | 11 | 17 | 17 | 12 | 29 | 40 | 43 | 50 | 54 | 75 | 65 | 67 |
OPM % | 23% | 20% | 25% | 22% | 17% | 28% | 29% | 31% | 36% | 36% | 35% | 31% | 31% |
1 | 4 | 3 | 3 | 5 | 3 | 13 | 7 | 6 | 5 | 11 | 20 | 18 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 9 | 13 | 14 | 15 |
Profit before tax | 11 | 13 | 18 | 17 | 14 | 29 | 49 | 45 | 52 | 50 | 72 | 71 | 70 |
Tax % | 27% | 30% | 28% | 25% | 22% | 26% | 20% | 23% | 28% | 25% | 25% | 23% | |
8 | 9 | 13 | 12 | 11 | 21 | 39 | 35 | 37 | 38 | 54 | 54 | 56 | |
EPS in Rs | 24.29 | 27.50 | 40.50 | 38.73 | 34.11 | 66.95 | 126.41 | 113.27 | 121.02 | 122.03 | 175.24 | 176.34 | 182.99 |
Dividend Payout % | 12% | 11% | 7% | 8% | 9% | 4% | 4% | 5% | 5% | 10% | 10% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 8% |
3 Years: | 14% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 9% |
3 Years: | 10% |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 16% |
3 Years: | -17% |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 14% |
3 Years: | 14% |
Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 35 | 42 | 54 | 65 | 80 | 110 | 174 | 224 | 269 | 302 | 351 | 405 | 434 |
1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
8 | 8 | 11 | 13 | 11 | 31 | 36 | 43 | 57 | 61 | 61 | 73 | 75 | |
Total Liabilities | 47 | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 | 512 |
10 | 9 | 18 | 20 | 35 | 37 | 38 | 41 | 51 | 147 | 149 | 152 | 146 | |
CWIP | 0 | 4 | 1 | 12 | 0 | 1 | 6 | 16 | 68 | 8 | 7 | 29 | 85 |
Investments | 14 | 18 | 19 | 18 | 33 | 53 | 116 | 163 | 154 | 151 | 182 | 223 | 190 |
23 | 23 | 30 | 31 | 26 | 54 | 54 | 50 | 56 | 61 | 78 | 77 | 91 | |
Total Assets | 47 | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 | 512 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 9 | 9 | 14 | 12 | 10 | 24 | 45 | 30 | 44 | 43 | 56 | |
0 | -7 | -8 | -13 | -11 | -10 | -0 | -43 | -29 | -42 | -38 | -50 | |
-3 | -2 | -1 | -1 | -2 | -1 | -23 | -2 | -2 | -2 | -4 | -5 | |
Net Cash Flow | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | -0 | 0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 102 | 96 | 114 | 97 | 83 | 135 | 85 | 69 | 85 | 97 | 90 | 90 |
Inventory Days | 133 | 117 | 96 | 117 | 125 | 118 | 122 | 131 | 148 | 233 | 180 | 177 |
Days Payable | 79 | 71 | 94 | 104 | 70 | 170 | 73 | 110 | 118 | 227 | 122 | 130 |
Cash Conversion Cycle | 155 | 142 | 116 | 110 | 138 | 83 | 133 | 89 | 115 | 103 | 149 | 137 |
Working Capital Days | 115 | 108 | 110 | 95 | 92 | 109 | 100 | 75 | 60 | 81 | 93 | 84 |
ROCE % | 30% | 30% | 32% | 25% | 12% | 29% | 27% | 21% | 20% | 17% | 21% | 17% |
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI (Listing Obligations And
Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Resumption Of Manufacturing Operations.
6 Dec - Resumption of manufacturing operations effective 6th December 2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 5 Dec
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3 Dec - In accordance with Regulation 30 of SEBI Listing Regulations, News Paper Advertisement related to notice of loss of equity shares certificate(s).
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
2 Dec - Intimation of lost share certificates and request for duplicates.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Nov - In accordance with Regulation 30 of SEBI Listing Regulations, news paper advertisement related to notice of loss of share certificate(s), for claiming the shares from …
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Products Offered
Paushak is part of the Alembic group of companies situated in Gujarat, India and is the largest specialty chemical company in India based on Phosgene Chemistry. Its products include Chloroformates, Isocyanates, Chlorides, Carbonates/Carbamate and Other Chemicals. These chemicals are used in diverse fields such as pesticides, pharmaceuticals dyes plastics and perfumeries. [1] [2]